Quick Answer
TherapeuticsMD, Inc. reported Long Term Debt Noncurrent of $0.00 for the year ending 2021.
- TherapeuticsMD, Inc. showed a decrease of -100.0% in Long Term Debt Noncurrent from 2020 to 2021.
- This data is from TherapeuticsMD, Inc.'s annual report (Form 10-K), filed with the SEC on March 23, 2022.
- XBRL data for this metric is available from 2018 to 2021 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2018: $73.14 million | Q3 2018: $73.26 million | Q1 2019: $73.50 million | Q2 2019: $194.10 million | Q3 2019: $194.36 million | Q1 2020: $243.43 million | Q2 2020: $243.80 million | Q3 2020: $237.05 million | Q1 2021: $178.97 million | Q2 2021: $175.26 million | Q3 2021: $171.74 million.
- Over the full 4 years of available data (2018 to 2021), TherapeuticsMD, Inc.'s Long Term Debt Noncurrent has declined by 100.0%.
- Historical annual values: Fiscal year 2021: $0.00 | Fiscal year 2020: $237.70 million | Fiscal year 2019: $194.63 million | Fiscal year 2018: $73.38 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: